A collection of Mov mouse strains, each carrying in their germ line a Moloney murine leukaemia virus (M-MuLV) proviral genome at a different chromosomal location, was used to study expression of endogenous retroviruses. No M-MuLVspecific RNA was detected in the non-viraemic Mov strains studied, indicating that less than two copies of RNA are transcribed per cell. Virus expression was seen in three viraemic Mov strains. In Mov-3 mice the provirus was activated shortly after birth, whereas proviruses in Mov-9 and Mov-14 were activated at different stages of embryogenesis. The results suggest that the chromosomal position influences proviral expression during development. The first appearance of virus particles was not accompanied by detectable amounts of viral transcripts, suggesting that viraemia is a consequence of provirus activation in a small, as yet unidentified, population of cells, followed by virus spread and infection of susceptible cells.
Over the past years, a number of transgenic mouse strains, each genetically transmitting the exogenous Moloney murine leukaemia virus (M-MuLV) at a single locus (Mov locus), have been derived in our laboratory (Jaenisch, 1976; J/ihner & Jaenisch, 1980; Jaenisch et al., 1981; Stewart et al., 1983; . The M-MuLV-carrying mouse strains (Mov mice) show different phenotypes of virus expression: some Mov strains become viraemic and, in two strains, virus activation has been shown to occur at different stages of development (Jaenisch et al., 1981) . Other Mov mice do not become viraemic during their lifetime. This is probably due to mutations in the structural region of the proviral genome which prevent formation of infectious virus particles but leave the transcriptional control region intact (Schnieke et al., 1983; Jaenisch et al., 1985) . The latter Mov strains allow the study of transcriptional activation of endogenous M-MuLV genomes without interference by spread of infectious virus particles. The Mov mice are useful model systems for studying virus-induced leukaemia and for analysing the relationship between provirus activation and its flanking host sequences. The present study was performed to determine at which stage of development and in which tissues the M-MuLV proviruses in the different Mov strains are activated, Embryos were obtained from timed matings; the day of the mating plug was counted as day 1 of gestation. Offspring of Mov-3 or embryos of Mov-9 were obtained by mating homozygous Mov-3 or Mov-9 males with C57BL/6 or 129 females, respectively. Mov-14 embryos were obtained by mating hemizygous Mov-14 males with C57BL/6 females. As the Mov-14 locus has been mapped on the X chromosome (Stewart et al., 1983) , only female embryos were expected to carry the Mov-14 locus. To confirm that litters used for studying provirus activation contained Mov-14 embryos, placental DNAs were isolated and used for genotype analysis as described by Stewart et al. (1983) . The appearance of infectious virus was studied by cocultivation of all cells from a given organ with NIH/3T3 fibroblasts to allow further spread of the virus. This provides a sensitive test for provirus activation but does not allow quantification of infectious particles. 
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The appearance of infectious virus was determined by a cocultivation assay as described in the text. Identical results were obtained for each Mov strain when embryos or offspring from three independent matings were studied.
t NT, Not tested. Whole embryos were tested. § The liver was tested separately from the rest of the embryo.
Organs from individual offspring (Mov-3) or from pooled embryos of individual litters (Mov-9 and Mov-14) were isolated and used for preparation of single cell suspensions as described previously (Nobis & Jaenisch, 1980) . All cells from a given organ were plated on NIH/3T3 cells grown to 30~ confluence in Dulbecco's modified Eagle's medium supplemented with 10~ foetal calf serum and 2 txg/ml polybrene in 75 cm 2 Falcon flasks. After 48 h, 5 ~ of the cells were transferred to 15 cm tissue culture plates and grown to confluence. The cultures were tested for production of M-MuLV by the XC plaque assay (Rowe et al., 1970) . Table 1 summarizes our results on the appearance of infectious M-MuLV during development of three different Mov strains. In Mov-3 mice, infectious virus was first detected in 4 day old animals in liver and in other organs. In contrast, the first appearance of infectious virus in Mov-9 and Mov-14 animals was seen in liver cells at day 18 or day 15 of gestation, respectively. Subsequently, virus appears in other organs. In Mov-14 embryos, brain and placenta are the last tissues of those tested that show infection. For each Mov strain, embryos or offspring from different matings were studied and in all cases the results shown in Table 1 were confirmed. To test whether the appearance of infectious virus particles is accompanied by detectable amounts of proviral transcripts, RNA was isolated from embryos or offspring at those developmental stages where the first infectious virus particles were detected and analysed by nuclease S1 protection assays. The results are shown in Fig. 1 (a)S1 nuclease mapping scheme. Nuclease S1 mapping was performed essentially as described (Weaver & Weissmann, 1979) . A 598 bp fragment extending from the SstI site in the 5' long terminal repeat (LTR) to the PstI site within the M-MuLV genome (Shinnick et al., 1981) was subcloned in the plasmid vector pSP64. For end-labelling, the subclone was cleaved with PstI and labelled by using [~,-3zp]ATP and polynucleotide kinase (Maniatis et al., 1982) . Finally, the plasmid was cleaved at the Pvull site in the vector, and a fragment containing the 598 bp from the PstI to the SstI site of the M-MuLV genome plus about 200 bp from the vector plasmid was separated by gel electrophoresis from the PvulI-PstI fragment of the vector. The PvulI-Pstl fragment (about 800 bp long) containing part of the M-MuLV genome, which was labelled on the PstI site only, was used for nuclease S1 protection experiments as described (Harbers et al., 1984) except that hybridization was done at 60 °C. A 563 bp long fragment is protected from SI nuclease digestion when hybridized to M-MuLV RNA. The 800 bp fragment represents the self-annealed DNA fragment. (b) S1 nuclease analysis of RNA isolated from Mov-3, Mov-9 and Mov-14 mice at the onset of viraemia. Lane 1, end-labelled marker fragments (~X174 digested with HaelII). Lanes 2, 3, 4 and 5, different amounts of RNA from the cell line C1 1-1a representing 200, 20, 2 and 0"2 copies of M-MuLV-specific RNA per cell, respectively. Lanes 6 and 7, RNA from liver and spleen, respectively, of Mov-3 mice at day 4 after birth. Lanes 8 and 9, RNA from liver and the rest of the embryo, respectively, of Mov-9 mice at day 18 of gestation. Lanes 10 and 11, RNA from liver and the rest of the embryo, respectively, of Mov-14 mice at day 17 of gestation. Lane 12, RNA from liver of C57BL mice at day 18 of gestation.
R N A per cell were included in the analysis (Simon et al., 1982) . Less than two copies per cell are still detectable under our experimental conditions ( Fig. 1 b, lane 4) . In contrast, no M -M u L V transcripts were found in liver or other organs o f offspring or embryos from Mov-3, Mov-9 and Mov-14 animals at the developmental stage where virus was detected by the cocultivation assay. These results show that activation of M -M u L V provirus in the M o v strains does not correlate with high level transcription in the tested tissues. U s i n g the same nuclease S1 protection assay, RNA isolated from various organs of 3 to 5 month old animals of the non-viraemic Mov strains 5, 6, 7, 8, 10 and 11 was analysed for the presence of M-MuLV-specific transcripts. No M-MuLV-specific RNA was detected under our assay conditions in brain, spleen, thymus, liver, heart, lung, kidney and testis, indicating that less than one to 10 copies of M-MuLV RNA per cell were present (data not shown). The same results were found when RNA from 16 day old embryos and newborn mice was analysed.
The results presented here show that provirus activatio n is detectable in viraemic Mov mice only and not in organs of any of the non-viraemic animals. The Mov-7 and Mov-10 strains carry mutations in the structural proviral genes (Schnieke et al., 1983) and transcripts are made after treatment of the animals with 5-azacytidine (Jaenisch et al., 1985) . The results presented here are in agreement with the observation that foreign genes are not expressed when introduced into the germ line of mice by retroviral vectors (e.g. see J/ihner et at., 1985) . The molecular mechanisms regulating provirus expression in Mov mice are not fully understood. DNA methylation has been shown to affect expression (J/ihner & Jaenisch, 1984) . The initial activation is not a stochastic event occurring in every cell with a certain probability but appears to be restricted (Fiedler et al., 1982) . In each of the three viraemic Mov strains studied, the provirus was activated at a different time during development (Table 1) . Infectious virus particles were found first in the liver. It is not clear if the initial activation took place in cells of this organ or if the provirus is activated in some other cells and the liver is the first organ where infection becomes measurable.
The results presented here suggest that the position of the provirus in the host genome influences the developmental stage of provirus activation. Previously, we have shown that in two other Mov strains, Mov-13 and Mov-1, provirus was activated during embryogenesis or after birth, respectively (Jaenisch et al., 1981) . It is not clear how the chromosomal region at which a viral genome has integrated influences its expression during development. It is possible that the transcriptional status of the flanking mouse sequences affects expression of the integrated provirus. Direct evidence for the position effect of provirus activation has recently been described (Barklis et al., 1986; .
Several of the Mov proviruses have recently been mapped by in situ hybridization and can therefore be used as genetic markers (Mfinke et al., 1986) . Furthermore, the viraemic Mov strains described here serve as a well-defined model system for studying the correlation between time of virus activation and development of leukaemia and for establishing schemes to prevent disease by passive immunotherapy (Nobis & Jaenisch, 1980) or by drugs which interfere with virus replication (A. Sharpe & R. Jaenisch, unpublished observation).
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